Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: A meta-analysis

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 4, 2015, Pages 402-410

  Zaccardi, Francesco ^a,b   Rocca, Bianca ^a   Pitocco, Dario ^a   Tanese, Luigi ^a   Rizzi, Alessandro ^a   Ghirlanda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Meta analysis; Platelet; Pre diabetic state; Review; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER;

ARTICLE; CELLULAR DISTRIBUTION; CROSS-SECTIONAL STUDY; DIET RESTRICTION; EMBASE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MEDLINE; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STANDARD; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; WEB OF SCIENCE; BLOOD; CARDIOVASCULAR DISEASES; CELL SIZE; COMPLICATION; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; EVIDENCE BASED MEDICINE; GLUCOSE INTOLERANCE; PATHOLOGY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION;

BIOMARKERS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL SIZE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; EVIDENCE-BASED MEDICINE; GLUCOSE INTOLERANCE; HUMANS; METABOLIC SYNDROME X; PLATELET ACTIVATION; PLATELET COUNT; PREDIABETIC STATE; RISK FACTORS;

EID: 84928105852     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2625     Document Type: Article

References (79)

1. Pan A, Malik VS, Hu FB. Exporting diabetes mellitus to Asia: the impact of Western-style fast food. Circulation 2012; 126(2): 163-165.
2. Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al.. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375(9733): 2215-2222.
3. Rocca B, Santilli F, Pitocco D, et al.. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost 2012; 10(7): 1220-1230.
4. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357(24): 2482-2494.
5. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al.. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373(9678): 1849-1860.
6. De Berardis G, Sacco M, Strippoli GF, et al.. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009; 339: b4531.
7. Rydén L, Grant PJ, Anker SD, et al.. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2014; 35(27): 1824.
8. Bessman JD. The relation of megakaryocyte ploidy to platelet volume. Am J Hematol 1984; 16(2): 161-170.
9. Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012; 44(8): 805-816.
10. Pascale S, Petrucci G, Dragani A, et al.. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. Blood 2012; 119(15): 3595-3603.
11. Buttarello M, Plebani M. Automated blood cell counts: state of the art. Am J Clin Pathol 2008; 130(1): 104-116.
12. Hoffmann JJ. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 2014; 52(8): 1107-1117.
13. Gonzalez-Porras JR, Martin-Herrero F, Gonzalez-Lopez TJ, et al.. The role of immature platelet fraction in acute coronary syndrome. Thromb Haemost 2010; 103(1): 247-249.
14. Chu SG, Becker RC, Berger PB, et al.. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8(1): 148-156.
15. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39, 531 participants from the general population. J Thromb Haemost 2011; 9(1): 49-56.
16. Han JY, Choi DH, Choi SW, et al.. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2013; 24(5): 401-406.
17. Lekston A, Hudzik B, Hawranek M, et al. Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. J Diabetes Complications 2014; May 16 [Epub ahead of print].
18. Vatankulu MA, Sonmez O, Ertas G, et al.. A new parameter predicting chronic total occlusion of coronary arteries: platelet distribution width. Angiology 2014; 65(1): 60-64.
19. De Luca G, Venegoni L, Iorio S, et al.. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets 2010; 21(7): 508-514.
20. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012; 59(7): 635-643.
21. Stroup DF, Berlin JA, Morton SC, et al.. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-2012.
22. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Visited 1/July/2014].
23. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 20(5): 13.
24. Lancé MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol 2010; 16(3): 28-31.
25. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets 2007; 18(8): 591-594.
26. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, Nakayama T. Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects. J Diabetes Investig 2014; 5(1): 66-71.
27. Abali G, Akpinar O, Söylemez N. Correlation of the coronary severity scores and mean platelet volume in diabetes mellitus. Adv Ther 2014; 31(1): 140-148.
28. Ateş O, Kiki I, Bilen H, et al.. Association of mean platelet volume with the degree of retinopathy in patients with diabetes mellitus. Eur J Gen Med 2009; 6(2): 99-102.
29. Avramakis G, Papadimitraki E, Papakonstandinou D, et al.. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets 2007; 18(1): 16-23.
30. Ayhan Tuzcu E, Arica S, Ilhan N, et al.. Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2014; 252(2): 237-240.
31. Bavbek N, Kargili A, Kaftan O, Karakurt F, Kosar A, Akcay A. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy? Clin Appl Thromb Hemost 2007; 13(4): 391-397.
32. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17(1): 67-69.
33. Dalamaga M, Karmaniolas K, Lekka A, et al.. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis Markers 2010; 29(1): 55-61.
34. Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications 2009; 23(2): 89-94.
35. Dindar S, Cinemre H, Sengul E, Annakkaya AN. Mean platelet volume is associated with glycaemic control and retinopathy in patients with type 2 diabetes mellitus. West Indian Med J 2013; 62(6): 519-523.
36. Dolasik I, Sener SY, Celebi K, Aydin ZM, Korkmaz U, Canturk Z. The effect of metformin on mean platelet volume in diabetic patients. Platelets 2013; 24(2): 118-121.
37. Hekimsoy Z, Payzin B, Ornek T, Kandoğan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 2004; 18(3): 173-176.
38. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988; 5(1): 63-69.
39. Inui Y, Suehiro T, Kumon Y, Hashimoto K. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus. J Atheroscler Thromb 1994; 1(2): 108-112.
40. Kim KY, Kim KE, Kim KH. Mean platelet volume in the normal state and in various clinical disorders. Yonsei Med J 1986; 27(3): 219-226.
41. Kim JH, Kang SB, Kang JI, Kim JW, Kim SY, Bae HY. The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a Korean general population: gender differences. Platelets 2013; 24(6): 469-473.
42. Kodiatte TA, Manikyam UK, Rao SB, et al.. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians 2012; 4(1): 5-9.
43. Lee EY, Kim SJ, Song YJ, Choi SJ, Song J. Immature platelet fraction in diabetes mellitus and metabolic syndrome. Thromb Res 2013; 132(6): 692-695.
44. Papanas N, Symeonidis G, Maltezos E, et al.. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15(8): 475-478.
45. Ravindran R, Krishnan LK. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Pathophysiol Haemost Thromb 2007; 36(1): 45-51.
46. Sahin DY, Gür M, Elbasan Z, et al.. Mean platelet volume and extent and complexity of coronary artery disease in diabetic and nondiabetic patients with ST elevation myocardial infarction. Angiology 2013; 64(7): 505-511.
47. Shah B, Sha D, Xie D, Mohler ER 3rd, Berger JS. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health and Nutrition Examination Survey, 1999-2004. Diabetes Care 2012; 35(5): 1074-1078.
48. Soogarun S, Wiwanitkit V, Suwansaksri J. Platelet count neither decreases nor relates to blood glucose level. Clin Appl Thromb Hemost 2004; 10(2): 187-188.
49. Tavil Y, Sen N, Yazici H, et al.. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets 2010; 21(5): 368-372.
50. Turgutalp K, Özhan O, Akbay E, et al.. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study. Clin Appl Thromb Hemost 2014; 20(2): 190-195.
51. Ulutas KT, Dokuyucu R, Sefil F, et al.. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? Int J Clin Exp Med 2014; 7(4): 955-961.
52. Verdoia M, Schaffer A, Barbieri L, et al.. Diabetes, glucose control and mean platelet volume: a single-centre cohort study. Diabetes Res Clin Pract 2014; 104(2): 288-294.
53. Watala C, Boncler M, Pietrucha T, Trojanowski Z. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity? Platelets 1999; 10(1): 52-60.
54. Zhong ZL, Han M, Chen S. Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. Int J Ophthalmol 2011; 4(2): 182-185.
55. Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J 2008; 49(2): 114-116.
56. Bostan F, Coban E. The relationship between levels of von Willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose. Med Sci Monit 2011; 17(6): PR1-4.
57. Demirtunc R, Duman D, Basar M. Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study. Clin Drug Investig 2007; 27(6): 435-441.
58. Jesri A, Okonofua EC, Egan BM. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich) 2005; 7(12): 705-711.
59. Kutlucan A, Bulur S, Kr S, et al.. The relationship between mean platelet volume with metabolic syndrome in obese individuals. Blood Coagul Fibrinolysis 2012; 23(5): 388-390.
60. Lippi G, Salvagno GL, Targher G, Guidi GC. Relationship between mean platelet volume and biochemical components of the metabolic syndrome. Clin Drug Investig 2007; 27(10): 731-732.
61. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007; 120(2): 245-250.
62. Yen-Lin C, Chun-Hsien H, Chang-Hsung H, et al.. Association between platelet count and components of metabolic syndrome in geriatric Taiwanese women. Int J Gerontol 2012; 6(3): 201-205.
63. Yen-Ling C, Chun P, Dee P, et al.. Association between platelet count and components of metabolic syndrome in geriatric Taiwanese males. Int J Gerontol 2012; 6(3): 215-219.
64. Davì G, Ciabattoni G, Consoli A, et al.. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99(2): 224-229.
65. El Haouari M, Rosado JA. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis 2008; 41(1): 119-123.
66. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32(5): 443-460.
67. Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA. The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol 2012; 9(11): 658-670.
68. Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 2008; 111(3): 981-986.
69. Patrono C, Rocca B, De Stefano V. Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. Blood 2013; 121(10): 1701-1711.
70. Dragani A, Pascale S, Recchiuti A, et al.. The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. Blood 2010; 115(5): 1054-1061.
71. Perl L, Lerman-Shivek H, Rechavia E, et al.. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014; 63(6): 513-517.
72. Asher E, Fefer P, Shechter M, et al.. Increased mean platelet volume is associated with non-responsiveness to clopidogrel. Thromb Haemost 2014; 112(1): 137-141.
73. Nakamura T, Uchiyama S, Yamazaki M, Okubo K, Takakuwa Y, Iwata M. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res 2002; 106(4-5): 171-177.
74. Lakkis N, Dokainish H, Abuzahra M, et al.. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 2004; 44(10): 2091-2093.
75. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 2004; 126(6): 861-869.
76. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol 2007; 29(2): 77-91.
77. Fadini GP, Albiero M, Vigili de Kreutzenberg S, et al.. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 2013; 36(4): 943-949.
78. Nagareddy PR, Murphy AJ, Stirzaker RA, et al.. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 2013; 17(5): 695-708.
79. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology 2006; 11(5): 317-319.